Skip to content
StockMarketAgent
Direct answer
NVDA trades against a final fair-value range of $189.63-$384.85, with the midpoint set by the accepted valuation synthesis rather than earlier draft model outputs. Fair value range: low $190, high $385, with mid-point at $282.
Stock analysis

NVDA NVDA fair value $190–$385

NVDA
By StockMarketAgent.AI team· supervised by
Analyzed: 2026-05-12Next update: 2026-08-12Methodology v2.4Review: automatedArchetype: Hyper-growth
View archive
Last price
$216.73
▲ +64.99 (+29.99%)
Fair value
$282
$190–$385
Rating
Strong Buy
confidence 87/100
Upside
+30.0%
upside to fair value
Margin of Safety
$239.46
MoS level · 15%
Market Cap
$5.27T
P/E fwd 19.2

§1 Executive summary

  • Composite fair value $282 with high case $385.
  • Implied upside of 30.0% to fair value.
  • Moat 9.5/10 · confidence 87/100 · Hyper-growth.
  • Trades below fair value with a meaningful cushion to the midpoint.
Fair value
$282
Margin of safety
+23.1%
Confidence
87/100
Moat
9.5/10

Educational analysis only — not financial advice. Always do your own due diligence.

$216.73Price
Low $189.63
Mid $281.72
High $384.85

NVDA trades against a final fair-value range of $189.63-$384.85, with the midpoint set by the accepted valuation synthesis rather than earlier draft model outputs.

  • CUDA ecosystem creates immense developer
    CUDA ecosystem creates immense developer lock-in.
  • Unmatched accelerated computing hardware performance
    Unmatched accelerated computing hardware performance and networking interconnects.
  • Bull thesis
    Anchoring on FCFF provides a necessary safety margin against extreme accrual risks flagged by the Beneish M-Score.

§2 Bear case

A stress test applying historical semiconductor cyclicality and a reversion to sector-median margins (35%) would devastate the valuation. While the FCFFFree cash flow to firmCash flow available to all capital providers (debt and equity) before financing costs. Discounted at WACC to derive enterprise value. anchor partially insulates against accrual risks, prolonged $9.5B+ annual capexCapital expendituresCash spent on acquiring or upgrading property, plant, and equipment. Splits into maintenance capex (sustaining current capacity) and growth capex (expanding capacity). without matching revenue growthRevenue growthYear-over-year change in revenue, expressed as a percentage. The starting point for any forward-earnings model and the lens through which scale, mix, and pricing power become visible. drives the target toward the $139.80 discounted earnings floor.

Ways this thesis can break

Hyperscaler Capex Cliff

· Medium

Major cloud providers abruptly halt AI infrastructure build-outs as ROI on AI deployments fails to materialize, leading to a severe revenue contraction.

FV impact
Severe (Target approaches $189.63 low)
Trigger
12-18 months

ASIC Substitution Surge

· Low

Custom silicon heavily displaces NVIDIA GPUs in hyperscaler workloads, breaking the CUDA monopoly and forcing severe margin compression.

FV impact
High (Margin regression below 50%)
Trigger
24-36 months

Export Control Escalation

· Medium

Geopolitical tensions result in total bans on advanced chip sales to critical international markets, permanently cutting off a major revenue segment.

FV impact
Moderate to High
Trigger
6-12 months
Early-warning signals to monitor
MetricCurrentTrigger threshold
Consecutive quarters of declining operating margins below 60%.MonitorDeterioration versus the report thesis
Hyperscaler capex guidance revised downward during earnings calls.MonitorDeterioration versus the report thesis
Inventory days outstanding increasing significantly above historical norms.MonitorDeterioration versus the report thesis
Deterioration in OCF to Net Income ratio (currently 0.856).MonitorDeterioration versus the report thesis
Further degradation of Beneish M-Score indicating elevated accruals.MonitorDeterioration versus the report thesis

§3 Financial history

Income statement — last six periods
Line itemT−0T−1T−2T−3CAGR
Period2023-01-312024-01-312025-01-312026-01-31Trend
Revenue$26.97B$60.92B$130.50B$215.94B+100.0%
Gross profit$15.36B$44.30B$97.86B$153.46B+115.4%
Operating income$5.58B$32.97B$81.45B$130.39B+185.9%
Net income$4.37B$29.76B$72.88B$120.07B+201.8%
EPS (diluted)$0.17$1.19$2.94$4.90+204.2%
EBITDA$5.99B$35.58B$86.14B$144.55B+189.0%
R&D$7.34B$8.68B$12.91B$18.50B+36.1%
SG&A$2.44B$2.65B$3.49B$4.58B+23.3%

Quality scores

Piotroski F-score
4 / 9
0–9 quality composite
Altman Z-score
57.3
Bankruptcy risk (>3 safe)
Beneish M-score
-1.13
Earnings manipulation risk
OCF / Net income
0.86×
>1 indicates high earnings quality
Accounting quality gate
Fail
Sector-adjusted gate
ROIC
66.5%
Return on invested capital
§3

Numbers analysis

Individual subscribers — §4 onwards11 more sections

Read the full analysis — 11 more sections.

Competitive moat, industry cycle, peer comparison, intrinsic valuation, sensitivity, scenarios, earnings decision tree, position management, investor perspectives, scorecard, and final recommendation.

Full report for every covered ticker
24 months of rating archive
Watchlist briefings + rating-change alerts
PDF + DOCX export in any language
Start free trial
Cancel anytime.
FAQ

NVDA — frequently asked questions

  1. Based on our latest analysis, NVDA looks meaningfully undervalued. The current price is $217 versus a composite fair-value midpoint of $282 (range $190–$385), which implies roughly 30.0% upside to the midpoint.
Related coverage

Names readers of NVDA also follow

Same archetype: hyper-growth